Skip to content

Effectiveness of Buddhist Monks in Providing Cognitive Behavior Therapy

A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01706731
Acronym
Add-CBT
Enrollment
62
Registered
2012-10-15
Start date
2012-10-31
Completion date
2013-10-31
Last updated
2012-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Buddhist monks, CBT, elderly, depression

Brief summary

This research is to study the effectiveness of cognitive behavioral therapy-CBT and Psychotherapy by trained buddhist monks. There are generally accepted that both cognitive and Buddhist concepts are related. This randomized controlled trial is to study the elderly participants who suffer major depressive disorder according to DSM-IV. The subjects will be divided into two groups. The experimental group will receive 12 sessions of CBT 2 times per week for 6 weeks in addition to usual treatment. The control group will receive treatment as usual and general conversation (non-CBT) with monks. Pretreatment factors (such as attachment style, interpersonal factors) of both therapist monks and patient participants will be studied.

Interventions

BEHAVIORALTreatment as usual

Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.

BEHAVIORALCognitive-behavioral therapy

Cognitive behavioral therapy(CBT)includes psychoeducational components combined with cognitive interventions targeted at challenging negative automatic thoughts.

Sponsors

Chiang Mai University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Meet criteria for Major depressive disorder * receiving antidepressant

Exclusion criteria

* presence of intense suicidal intent behaviors that require inpatient admission * history of alcohol or drug dependence * presence of hallucinations or delusions * currently receiving electroconvulsive therapy or repetitive-transcranial magnetic stimulation, * patients' involvement in other clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Evidence of clinically depression confirmed by clinician2 months after the end of the interventionDepression will be assessed by HAMD-7 (McIntyre, 2005)
Depression- self report2 month after the end of the inetrventiondepression will be assessed by Geriatric Depression Scale (GDS)(Shiekh & Yesavage, 1986)

Secondary

MeasureTime frameDescription
Dimensional psychological distress (anxiety, depression,and somatization)week 6, 12, 20anxiety, depression,and somatization symptom will be assessed by the Core symptom index (CSI) (Wongpakaran, unpublished),
Dimensional psychological distress ( perception of stress)Week 6, 12, 20Perception of stress will be assessed by Perceived Stress Scale-10 (PSS-10) (Cohen 1983 ; Wongpakaran, 2010)

Other

MeasureTime frameDescription
working allianceafter session 3, 6, and 12Working alliance will be assessed by the Helping Alliance Questionnaire (HAQ)(Luborsky, 1996)
Pretreatment measure (attachment)at baselineThe part includes participants' attachment which will be assessed by the revised Experience of Close Relationships Questionnaire (ECR-R 18)(Wongpakaran, 2012)
Pretreatment measure (interpersonal problems)at baselineInterpersonal problems will be assessed by the inventory of interpersonal problems(Horowitz, 2000)
Pretreatment measure(neuroticism)at baselineNeuroticism will be assessed by the Neuroticsm Inventory (Wongpakaran,unpublished)

Countries

Thailand

Contacts

Primary ContactNahathai - Wongpakaran, M.D.
nkuntawo@med.cmu.ac.th+66 53 945422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026